Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1988 2
1989 2
1990 1
1991 2
1992 2
1996 2
1998 1
1999 4
2000 5
2001 1
2002 6
2003 7
2004 3
2005 9
2006 8
2007 5
2008 1
2009 4
2010 3
2019 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Results by year

Filters applied: . Clear all
Page 1
Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008.
Brüggemann M, Schrauder A, Raff T, Pfeifer H, Dworzak M, Ottmann OG, Asnafi V, Baruchel A, Bassan R, Benoit Y, Biondi A, Cavé H, Dombret H, Fielding AK, Foà R, Gökbuget N, Goldstone AH, Goulden N, Henze G, Hoelzer D, Janka-Schaub GE, Macintyre EA, Pieters R, Rambaldi A, Ribera JM, Schmiegelow K, Spinelli O, Stary J, von Stackelberg A, Kneba M, Schrappe M, van Dongen JJ; European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL); International Berlin-Frankfurt-Münster Study Group (I-BFM-SG). Brüggemann M, et al. Among authors: janka schaub ge. Leukemia. 2010 Mar;24(3):521-35. doi: 10.1038/leu.2009.268. Epub 2009 Dec 24. Leukemia. 2010. PMID: 20033054 Review.
Results of CoALL 07-03 study childhood ALL based on combined risk assessment by in vivo and in vitro pharmacosensitivity.
Schramm F, Zur Stadt U, Zimmermann M, Jorch N, Pekrun A, Borkhardt A, Imschweiler T, Christiansen H, Faber J, Schmid I, Feuchtinger T, Beron G, den Boer ML, Pieters R, Horstmann MA, Janka-Schaub GE, Escherich G. Schramm F, et al. Among authors: janka schaub ge. Blood Adv. 2019 Nov 26;3(22):3688-3699. doi: 10.1182/bloodadvances.2019000576. Blood Adv. 2019. PMID: 31765480 Free PMC article.
Methotrexate resistance in relapsed childhood acute lymphoblastic leukaemia.
Rots MG, Pieters R, Peters GJ, Noordhuis P, Van Zantwijk CH, Henze G, Janka-Schaub GE, Veerman AJ, Jansen G. Rots MG, et al. Among authors: janka schaub ge. Br J Haematol. 2000 Jun;109(3):629-34. doi: 10.1046/j.1365-2141.2000.02071.x. Br J Haematol. 2000. PMID: 10886214 Free article.
Outcome of treatment in children with hypodiploid acute lymphoblastic leukemia.
Nachman JB, Heerema NA, Sather H, Camitta B, Forestier E, Harrison CJ, Dastugue N, Schrappe M, Pui CH, Basso G, Silverman LB, Janka-Schaub GE. Nachman JB, et al. Among authors: janka schaub ge. Blood. 2007 Aug 15;110(4):1112-5. doi: 10.1182/blood-2006-07-038299. Epub 2007 May 1. Blood. 2007. PMID: 17473063 Free PMC article. Clinical Trial.
[Familial hemophagocytic lymphohistiocytosis].
Hesse C, Hansmann ML, Janka-Schaub GE, Rontogianni D, Radzun HJ, Fischer R. Hesse C, et al. Among authors: janka schaub ge. Verh Dtsch Ges Pathol. 1991;75:200-4. Verh Dtsch Ges Pathol. 1991. PMID: 1724833 German.
65 results